-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Small Molecules For Breast Cancer in Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Small Molecules For Breast Cancer in Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Small Molecules For Breast Cancer in Breast Cancer...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Small Molecule To Antagonize ADORA For Central Nervous System in Narcolepsy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Small Molecule To Antagonize ADORA For Central Nervous System in Narcolepsy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Small Molecule To Antagonize ADORA...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Small Molecule To Inhibit CDK9 For HIV Infections And Oncology in Human Immunodeficiency Virus (HIV) Infections (AIDS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Small Molecule To Inhibit CDK9 For HIV Infections And Oncology in Human Immunodeficiency Virus (HIV) Infections (AIDS) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Small Molecule To Target PSMA For Metastatic Hormone Refractory Prostate Cancer in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Small Molecule To Target PSMA For Metastatic Hormone Refractory Prostate Cancer in Metastatic Castration-Resistant Prostate Cancer (mCRPC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical...
-
Product Insights
Intercellular Adhesion Molecule 1 – Drugs In Development, 2023
Global Markets Direct’s Intercellular Adhesion Molecule 1 provides in depth analysis on Intercellular Adhesion Molecule 1 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Intercellular Adhesion Molecule...
-
Product Insights
Mucosal Addressin Cell Adhesion Molecule 1 – Drugs In Development, 2023
Global Markets Direct’s Mucosal Addressin Cell Adhesion Molecule 1 provides in depth analysis on Mucosal Addressin Cell Adhesion Molecule 1 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved...
-
Product Insights
Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 – Drugs In Development, 2023
Global Markets Direct’s Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 provides in depth analysis on Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 – Drugs In Development, 2023
Global Markets Direct’s Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 provides in depth analysis on Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Sector Analysis
NewFuture of Pharma – Looking Ahead to 2024
This report provides a summary of the near and long-term future of the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, and market-based analysis, allowing you to discern the large-scale changes and how best to pivot and prioritize them within your sectors.